Stanford investigates Long-Term chelation results for MRI-Related illness
NCT ID NCT06269055
Summary
This study aims to understand the long-term benefits and side effects of chelation therapy for people with Gadolinium Deposition Disease (GDD), a condition linked to MRI contrast agents. Researchers will collect information from 50 adults who have already completed at least five rounds of DTPA chelation treatment. The study focuses on tracking changes in symptoms like pain, cognitive issues, and disability over time through questionnaires.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GADOLINIUM DEPOSITION DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University Medical Center
RECRUITINGStanford, California, 94305, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.